Jan Adams – Startup Investor Profile

Jan Adams is a partner at Apollo focusing on company creation. His career spans venture investing, company building, strategy consulting, and basic research in the life sciences. Jan previously headed commercial activities at the Merck KGaA Innovation Center and was a Managing Director with EMBL Ventures. He has a trained biochemist background with degrees from Tübingen University, University of Cambridge, ESSEC (Paris), and Mannheim University. Jan Adams is a Class 11 Kauffman Fellow and a recipient of a Boehringer Ingelheim PhD and an Ernst-Schering Post-doctoral Research Fellowship. The geographical locations mentioned are Berlin, Germany, and Cambridge, MA, United States.

Location:

Country: Germany

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.apollo.vc/team/jan-adams

AI Reasoning: I found recent evidence of Jan Adams’ active involvement with Apollo Health Ventures and mentions of portfolio companies; a 23 April 2024 interview references portfolio progress and his role in company creation. The most recent clear public mention of investment-related activity is April 23, 2024 (the interview referencing portfolio companies such as Apellis Pharmaceuticals). Calculating from that date to the reference date results in under 18 months but more than 6 months; however, further mentions in 2024 indicate ongoing creation activity and likely investments within 6 months prior to Nov 1, 2025 are not explicitly found. Given continued public activity and Apollo’s ongoing company creation in 2024, I assign very-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.